Gout with Severe Renal Impairment (eGFR <30 mL/min): What to Do When Acute Flare Treatment Has Not Achieved Full Resolution
Clinical Scenario
This protocol applies to patients with gout who have severe renal impairment — defined as an estimated glomerular filtration rate (eGFR) below 30 mL/min. This level of renal impairment critically limits which treatments can be used safely and how they must be dosed.
When the Initial Approach Was Not Enough
For an acute gout flare in this population, the first-line approach uses oral prednisolone or articular aspiration with corticosteroid injection — colchicine and NSAIDs are both avoided because of the severity of renal impairment. This protocol represents the next step when that initial management has not achieved its primary goal: resolution of the acute flare with full relief of joint pain and inflammation.
Treatment Approach (Partial Overview)
The next step centres on allopurinol, with the maximum dose calibrated to the patient's creatinine clearance given the severity of renal impairment, combined with structured lifestyle guidance. The complete protocol specifies how this is applied.
Treatment Targets
- Serum uric acid level below 6 mg/dL (360 mmol/L), maintained lifelong
- For patients with severe gout, a lower target below 5 mg/dL (300 mmol/L) until total crystal dissolution
References
DOI: 10.1136/annrheumdis-2016-209707
- Colchicine and NSAIDs should be avoided in patients with severe renal impairment.
- The safe use of colchicine in patients with severe renal impairment (GFR <30 mL/min) has not been established.
- Because colchicine clearance is decreased in patients with severe renal impairment, the group considered that it should be avoided in these patients, because a reduced dosage might be a source of therapeutic misuse.
- In patients with renal impairment, the allopurinol maximum dosage should be adjusted to creatinine clearance.
- Every person with gout should receive advice regarding lifestyle: weight loss if appropriate and avoidance of alcohol (especially beer and spirits) and sugar-sweetened drinks, heavy meals and excessive intake of meat and seafood.
- Low-fat dairy products should be encouraged.
- Regular exercise should be advised.
- For patients on ULT, SUA level should be monitored and maintained to <6 mg/dL (360 mmol/L).
- A lower SUA target (<5 mg/dL; 300 mmol/L) to facilitate faster dissolution of crystals is recommended for patients with severe gout (tophi, chronic arthropathy, frequent attacks) until total crystal dissolution and resolution of gout.
- SUA <6 mg/dL (360 mmol/L) should be maintained lifelong.
View source ↗